Repligen
- Market cap
- 10.62B
- P/E (TTM)i
- 229.07
- P/Bi
- 5.03
- EPSi
- 0.86
- Div yieldi
- 0.00%
- 52W posi
- 68%
Anonymous reader poll. Unscientific, not investment advice.
Repligen ended the session at 167.22, down 4.37%. Its market capitalisation is about 10.62B, the #1445 most valuable US-listed company we track. The trailing P/E of 259.40 is 114% above its five-year average of 121.01. Across 10 analysts the consensus rating is Buy, with an average price target of 184.29 (+10%). The shares sit 68% of the way up their 52-week range of 100.99 to 198.87.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 2 days.
- Recent price momentum is +17.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 11.9% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 174.86
- Open
- 174.75
- Day range
- 165.99 - 175.04
- Avg price
- 168.10
- Volume
- 2.63M
- Turnover
- 442.13M
- Turnover ratei
- 4.35%
- Volume ratioi
- 1.75
- Amplitudei
- 5.18%
- 52-week rangei
- 100.99 - 198.87
Valuation
- P/Ei
- 194.44
- P/E (TTM)i
- 229.07
- P/Bi
- 5.03
- EPSi
- 0.86
- Book value / shi
- 33.27
- Net profit
- 54.60M
- Net assets
- 2.11B
Share structure
- Market cap
- 10.62B
- Float capi
- 10.12B
- Shares out
- 63.49M
- Float sharesi
- 60.53M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
15.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-25.49M net over the window
Short interest
- Shares short
- 6.71M
- % of floati
- 11.89%
- Days to coveri
- 7.09
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Repligen (RGEN)?
Repligen last traded at 167.22. The quote on this page refreshes every few seconds while US markets are open.
What is Repligen's market cap?
About 10.62B.
What is the P/E ratio of Repligen?
The trailing twelve-month P/E is 229.07, above its own 5-year average of 121.01 — toward the top of its historical range (86.67% percentile). See the Valuation tab for the full history.
Does Repligen pay a dividend?
Repligen does not currently pay a regular dividend.
Is Repligen a buy according to analysts?
The consensus of 10 analysts is a Buy rating, with an average 12-month price target of 184.29, which implies 10.2% upside from the current price. This is not investment advice.
What is Repligen's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Repligen a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 08:43:47 · For reference only, not investment advice and not tailored to your situation.